Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hunt

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
The Journal of Infectious Diseases|March 27, 2012
CD28-negative CD4+ and CD8+ T cells in antiretroviral therapy-naive HIV-infected adults enrolled in adult clinical trials group studiesKatherine Tassiopoulos, Alan Landay, Ann C Collier, et al.
Plos One|April 22, 2009
Human herpesvirus replication and abnormal CD8+ T cell activation and low CD4+ T cell counts in antiretroviral-suppressed HIV-infected patientsMark A Jacobson, Dirk P Ditmer, Elizabeth Sinclair, et al.
Journal of Rehabilitation Research and Development|May 9, 2006
Issues in maintenance and repairs of wheelchairs: A pilot studyShirley G Fitzgerald, Diane M Collins, Rory A Cooper, et al.
Journal of Neurochemistry|September 3, 2004
Conserved residues within the putative active site of gamma-secretase differentially influence enzyme activity and inhibitor bindingJonathan D J Wrigley, Emma J Nunn, Omar Nyabi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 18, 2015
Age at Entry Into Care, Timing of Antiretroviral Therapy Initiation, and 10-Year Mortality Among HIV-Seropositive Adults in the United StatesJessie K Edwards, Stephen R Cole, Daniel Westreich, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2012
Discovery of a novel chemotype of potent human ENaC blockers using a bioisostere approach. Part 2: α-Branched quaternary aminesThomas Hunt, Hazel C Atherton-Watson, Stephen P Collingwood, et al.
The Journal of Infectious Diseases|January 6, 2007
Interruption of enfuvirtide in HIV-1 infected adults with incomplete viral suppression on an enfuvirtide-based regimenSteven G Deeks, Jing Lu, Rebecca Hoh, et al.
Medrxiv : the Preprint Server for Health Sciences|August 7, 2023
Impact of Kaposi Sarcoma on Quality of Life Amongst HIV-infected Adults Initiating Antiretroviral Therapy in East AfricaLu Scott, Miriam Laker-Oketta, Helen Byakwaga, et al.
Journal of the American Heart Association|April 30, 2019
Carnitine Is Associated With Atherosclerotic Risk and Myocardial Infarction in HIV -Infected AdultsArjun Sinha, Yifei Ma, Rebecca Scherzer, et al.
Brain, Behavior, and Immunity|April 22, 2018
Recent stimulant use and leukocyte gene expression in methamphetamine users with treated HIV infectionAdam W Carrico, Annesa Flentje, Kord Kober, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
The Journal of Infectious Diseases|March 27, 2012
CD28-negative CD4+ and CD8+ T cells in antiretroviral therapy-naive HIV-infected adults enrolled in adult clinical trials group studiesKatherine Tassiopoulos, Alan Landay, Ann C Collier, et al.
Plos One|April 22, 2009
Human herpesvirus replication and abnormal CD8+ T cell activation and low CD4+ T cell counts in antiretroviral-suppressed HIV-infected patientsMark A Jacobson, Dirk P Ditmer, Elizabeth Sinclair, et al.
Journal of Rehabilitation Research and Development|May 9, 2006
Issues in maintenance and repairs of wheelchairs: A pilot studyShirley G Fitzgerald, Diane M Collins, Rory A Cooper, et al.
Journal of Neurochemistry|September 3, 2004
Conserved residues within the putative active site of gamma-secretase differentially influence enzyme activity and inhibitor bindingJonathan D J Wrigley, Emma J Nunn, Omar Nyabi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 18, 2015
Age at Entry Into Care, Timing of Antiretroviral Therapy Initiation, and 10-Year Mortality Among HIV-Seropositive Adults in the United StatesJessie K Edwards, Stephen R Cole, Daniel Westreich, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2012
Discovery of a novel chemotype of potent human ENaC blockers using a bioisostere approach. Part 2: α-Branched quaternary aminesThomas Hunt, Hazel C Atherton-Watson, Stephen P Collingwood, et al.
The Journal of Infectious Diseases|January 6, 2007
Interruption of enfuvirtide in HIV-1 infected adults with incomplete viral suppression on an enfuvirtide-based regimenSteven G Deeks, Jing Lu, Rebecca Hoh, et al.
Medrxiv : the Preprint Server for Health Sciences|August 7, 2023
Impact of Kaposi Sarcoma on Quality of Life Amongst HIV-infected Adults Initiating Antiretroviral Therapy in East AfricaLu Scott, Miriam Laker-Oketta, Helen Byakwaga, et al.
Journal of the American Heart Association|April 30, 2019
Carnitine Is Associated With Atherosclerotic Risk and Myocardial Infarction in HIV -Infected AdultsArjun Sinha, Yifei Ma, Rebecca Scherzer, et al.
Brain, Behavior, and Immunity|April 22, 2018
Recent stimulant use and leukocyte gene expression in methamphetamine users with treated HIV infectionAdam W Carrico, Annesa Flentje, Kord Kober, et al.
Pageof 9